Injectable Cytotoxic Drugs Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027, The global injectable cytotoxic drugs market size is expected to reach USD 29.60 billion by 2027, exhibiting a CAGR of 8.1% during the forecast period. The rising cases of cancer have resulted in high dependency on cytotoxic drugs, which, in turn, will bolster healthy growth of the market, states Fortune Business Insights, in a report, titled “Injectable Cytotoxic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Alkylating Drugs, Cytotoxic Antibodies, Antimetabolites, Plant Alkaloids, and Others), By Application (Oncology, Rheumatoid Arthritis, Multiple Sclerosis, and Others) By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The market size stood at USD 15.81 billion in 2019.
The Report Lists the Key Companies in the Injectable Cytotoxic Drugs Market:
- Johnson and Johnson Services Inc., (U.S)
- Sanofi (France)
- Eli Lilly and Company (U.S)
- Bristol-Myers Squibb Company (New York, U.S)
- Hoffmann-La Roche Ltd. (Basel, Switzerland)
- Novartis AG (Basel, Switzerland)
- Pfizer, Inc (New York, U.S)
- Merck & Co. Inc (New Jersey, U.S)
- Amgen (California, U.S.)
Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/injectable-cytotoxic-drugs-market-104705
Injectable Cytotoxic Drugs Market Analysis 2021:
Surging Demand for Injectable Cytotoxic Drugsto Contribute Impetus During Coronavirus
The COVID-19 had a promising effect on the global market. The excessive demand for drugs attributed to the COVID-19 emergency can have an outstanding impact on the cytotoxic drugs business. The pharmaceutical companies are focused on supply chain management, enhanced capabilities, and investments in manufacturing management and quality control, which, in turn, will boost the market growth. According to the quarterly reports of 2020 of Roche, their global supply chain of medicines and tests remained intact. Their pharmaceutical division sales increased by 7% compared to the prior year. This growth was led by oncology drugs such as Tecentriq and Perjeta. Hence, the growing supply and demand for injectable cytotoxic drugs therapies will enable speedy expansion of the market amid coronavirus.
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain this global pandemic.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Rising Prevalence of Cancer and Rheumatoid Arthritis to Drive Market
The increasing incidence of cancer due to various environmental factors such as tobacco smoking, urbanization, and changing diet patterns will spur growth opportunities for the market. According to the World Health Organization (WHO), cancer is a growing burden, and the number of new cancer cases are expected to rise from 18.1 million in 2018 to 29.4 million by 2040. Moreover, the rising prevalence of rheumatoid arthritis and multiple sclerosis will have a tremendous impact on the market in the forthcoming years. The growing awareness about the benefits of injectable cytotoxic drugs in cancer treatment can encourage the market’s healthy growth. According to the Center for Disease Control and Prevention, around 41 individuals out of 100,000 are affected with rheumatoid arthritis each year in the U.S.
Detailed Table of Content:
1 Injectable Cytotoxic Drugs Market Overview
1.1 Injectable Cytotoxic Drugs Product Overview
1.2 Injectable Cytotoxic Drugs Market Segment by Type
1.3 Global Injectable Cytotoxic Drugs Market Size by Type (2015-2027)
1.3.1 Global Injectable Cytotoxic Drugs Market Size Overview by Type (2015-2027)
1.3.2 Global Injectable Cytotoxic Drugs Historic Market Size Review by Type (2015-2021)
220.127.116.11 Global Injectable Cytotoxic Drugs Sales Market Share Breakdown by Type (2015-2027)
18.104.22.168 Global Injectable Cytotoxic Drugs Market Share Breakdown by Type (2015-2027)
22.214.171.124 Global Injectable Cytotoxic Drugs Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global Injectable Cytotoxic Drugs Market Size Forecast by Type (2021-2027)
126.96.36.199 Global Injectable Cytotoxic Drugs Sales Market Share Breakdown by Application (2021-2027)
188.8.131.52 Global Injectable Cytotoxic Drugs Revenue Market Share Breakdown by Application (2021-2027)
184.108.40.206 Global Injectable Cytotoxic Drugs Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Injectable Cytotoxic Drugs Sales Breakdown by Type (2015-2027)
1.4.2 Europe Injectable Cytotoxic Drugs Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific Injectable Cytotoxic Drugs Sales Breakdown by Type (2015-2027)
1.4.4 Latin America Injectable Cytotoxic Drugs Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa Injectable Cytotoxic Drugs Sales Breakdown by Type (2015-2027)
2 Global Injectable Cytotoxic Drugs Market Competition by Company
2.1 Global Top Players by Injectable Cytotoxic Drugs Sales (2015-2021)
2.2 Global Top Players by Injectable Cytotoxic Drugs Revenue (2015-2021)
2.3 Global Top Players Injectable Cytotoxic Drugs Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Injectable Cytotoxic Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Injectable Cytotoxic Drugs Market Competitive Situation and Trends
2.5.1 Injectable Cytotoxic Drugs Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Injectable Cytotoxic Drugs Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Cytotoxic Drugs as of 2019)
2.7 Date of Key Company Enter into Injectable Cytotoxic Drugs Market
2.8 Key Company Injectable Cytotoxic Drugs Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Injectable Cytotoxic Drugs Status and Outlook by Region (2015-2027)
3.1 Global Injectable Cytotoxic Drugs Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global Injectable Cytotoxic Drugs Market Size Market Share by Region (2015-2021)
3.2.1 Global Injectable Cytotoxic Drugs Sales Market Share by Region (2015-2021)
3.2.2 Global Injectable Cytotoxic Drugs Revenue Market Share by Region (2015-2021)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/injectable-cytotoxic-drugs-market-104705
KEY QUESTIONS ANSWERED:
- What are the key technological and Injectable Cytotoxic Drugs trends shaping the market?
- What are the key opportunities in the market?
- What are the key companies operating in the market?
- Which company accounted for the highest market share?
- Why Choose Fortune Business Insights?
- What is the market size and growth rate of the global and regional market by various segments?
- What is the market size and growth rate of the market for selective countries?
- Which region or sub-segment is expected to drive the market in the forecast period?
- What Factors are estimated to drive and restrain the Injectable Cytotoxic Drugs growth?
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245